Long-Term Follow-up Study

Enrolling by invitation

Conditions studied: Lymphoma, Non-Hodgkin, Relapsed Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B-Cell Non-Hodgkin's Lymphoma, Hematologic Malignancy, Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Acute Myeloid Leukemia

In brief

This is an observational, non-interventional, LTFS of investigational Caribou therapies in patients who have participated in a parent study: a prior Caribou-sponsored clinical study, special access program, or an IIT. The objective is to evaluate the long-term safety, through 15 years post infusion, in patients who received IPs in a Caribou-sponsored clinical study, special access program or IIT.

Key facts

Study ID

NCT05332054

Run by

Caribou Biosciences, Inc.

People needed

150

Starts

2022-03-16

Expected to finish

2041-12-01

Last updated by the study team

2026-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent (by patient or legal representative) obtained prior to study-specific activities/enrollment
• Completed a Caribou-sponsored study or was administered Caribou IP under a special access program or as part of an IIT
• Use of an effective method of birth control by women of childbearing potential and their partners and men with partners of childbearing potential (partners must also use an effective birth control method) through 12 months post IP infusion.

You may not qualify if…

• None

Where it is running

• University of Alabama — Birmingham, Alabama, United States
• Banner MD Anderson Cancer Center — Gilbert, Arizona, United States
• Honor Health Research Institute — Scottsdale, Arizona, United States
• University of California Irvine — Irvine, California, United States
• University of California San Diego — La Jolla, California, United States
• University of Colorado — Denver, Colorado, United States
• Colorado Blood Cancer Institute — Denver, Colorado, United States
• University of Miami — Miami, Florida, United States
• AdventHealth Medical Group Blood & Marrow Transplant at Orlando — Orlando, Florida, United States
• Blood & Marrow Transplant Group of Georgia — Atlanta, Georgia, United States
• Augusta University/Georgia Cancer Center — Augusta, Georgia, United States
• University of Iowa Hospitals & Clinics — Iowa City, Iowa, United States
• University of Kentucky — Lexington, Kentucky, United States
• Norton Cancer Institute — Louisville, Kentucky, United States
• Regional Cancer Care Associates - Hackensack — Hackensack, New Jersey, United States
• Atlantic Health System Cancer Care — Morristown, New Jersey, United States
• Weill Cornell Medicine — New York, New York, United States
• Icahn School of Medicine at Mt. Sinai — New York, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Levine Cancer Center — Charlotte, North Carolina, United States
• Oncology Hematology Care — Cincinnati, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Sarah Cannon Research Institute - TriStar Health — Nashville, Tennessee, United States
• University of Texas Southwestern — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.